Brainomix and 3DR Labs have entered a strategic partnership on the AI imaging tool Brainomix 360 Stroke.
In a statement, the companies said that they will integrate Brainomix 360 Stroke into 3DR’s AI Labs, a vendor-agnostic platform.
Brainomix 360 Stroke was recently granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) has granted 510(k) for a patented feature enabling assessment of ischemic core volume on noncontrast CT scans.
The collaboration follows 3DR Labs’ recent launch of its Neurology Center of Excellence, a new division focused on providing specialized postprocessing services for stroke, presurgical planning, and the management of brain and spine diseases.
